Skip to main content

Advertisement

Table 1 Baseline data (\( \overline{x} \)±s)

From: Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Group Patients Age (years) DBP (mmHg) SBP (mmHg) BMI (kg/m2)
 Diabetes 200 52 ± 0.25 75 ± 13 120 ± 14.5 24.8 ± 0.5
 Diabetes combined with hyperlipidemia 195 58 ± 0.18a 98 ± 9a 149 ± 13.5a 26.9 ± 0.8a
Group Total cholesterol (mmol/L) HDL (mmol/L) LDL (mmol/L) Smoking (%)
 Diabetes 5.2 ± 0.89 1.75 ± 0.18 1.36 ± 0.12 23.8%
 Diabetes combined with hyperlipidemia 5.9 ± 0.67a 2.68 ± 0.38a 2.45 ± 0.36a 38.5%a
Group FPG (mmol/L) Hypertension (%) Obesity (%) Follow-up period (year) hs-CRP (mg/L)
 Diabetes 9.45 ± 0.16 21.8 19.8 4.0 (3.8–4.2) 1.86 ± 0.45
 Diabetes combined with hyperlipidemia 9.04 ± 0.38a 35.9a 29.7a 4.2 (3.7–4.4)a 9.65 ± 0.82a
  1. Note: DBP diastolic blood pressure, SBP systolic blood pressure, BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, FPG fasting plasma glucose, hs-CRP hyper-sensitive C-reactive protein
  2. aP < 0.05